Opinion

Video

Zanubrutinib-Based Treatment Clinical Trial Updates

Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.

Related Videos
A panel of 3 experts on CML